Suppr超能文献

对于伴有淋巴结转移的进展期胃癌,腹腔镜根治性胃切除术与开腹胃切除术,哪种方法更适合?

Which method is more suitable for advanced gastric cancer with enlarged lymph nodes, laparoscopic radical gastrectomy or open gastrectomy?

机构信息

Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, Fujian Province, China.

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

Gastric Cancer. 2018 Sep;21(5):853-863. doi: 10.1007/s10120-018-0800-7. Epub 2018 Jan 30.

Abstract

BACKGROUND

The oncologic outcome of laparoscopic radical gastrectomy (LG) with open radical gastrectomy (OG) for gastric cancer with preoperative enlarged lymph nodes (LNs) remains ambiguous.

METHODS

The long-term outcomes of LG (n = 855) versus OG (n = 154) in gastric adenocarcinoma patients were analyzed retrospectively. Patients were stratified according to enlarged (> 10 mm) and small (≤ 10 mm) LNs (ELN and SLN) based on the long-axis diameter of the LNs.

RESULTS

The violin plot indicates that the distribution of ELN size was similar between two groups. Survival curves demonstrated that the overall survival (OS) in LG is enhanced compared with OG (p = 0.034). A stratified analysis revealed that the OS was better in the LG group compared with the OG group for patients with ELNs (p = 0.038). In a forest map analysis, the actual 3-year OS rate for LG was significantly increased compared with OG in enlarged suprapancreatic LN (ESLNs) patients. Stratified analysis based on different diameters of ESLNs revealed that the actual 3-year OS and cancer-specific survival (CSS)rate for LG was significant increased compared to OG with a diameter from 1.0 to 1.9 cm for pII or pIII stage patients. However, the actual 3-year OS and CSS rate for LG was significantly reduced compared with OG when the size exceeded 2.5 cm.

CONCLUSIONS

For advanced gastric cancer with an ESLN diameter from 1.0 to 1.9 cm, LG could be chosen preferentially; nevertheless, LG is not safe if ESLN are > 2.5 cm.

摘要

背景

术前淋巴结肿大(LNs)的胃癌患者行腹腔镜根治性胃切除术(LG)与开腹根治性胃切除术(OG)的肿瘤学结果仍存在争议。

方法

回顾性分析了胃腺癌患者 LG(n=855)与 OG(n=154)的长期结果。根据 LN 的长轴直径,患者分为淋巴结肿大(>10mm)和小淋巴结(≤10mm)(ELN 和 SLN)。

结果

小提琴图表明两组 ELN 大小的分布相似。生存曲线表明,LG 的总生存率(OS)优于 OG(p=0.034)。分层分析显示,LG 组的 OS 优于 OG 组,ELN 患者的 OS 更好(p=0.038)。在森林图分析中,LG 的实际 3 年 OS 率明显高于 OG 在扩大胰上淋巴结(ESLNs)患者中。基于不同直径的 ESLNs 的分层分析表明,LG 的实际 3 年 OS 和癌症特异性生存率(CSS)率在直径为 1.0 至 1.9cm 的 pII 或 pIII 期患者中明显高于 OG,而在直径超过 2.5cm 时,LG 的实际 3 年 OS 和 CSS 率明显低于 OG。

结论

对于 ESLN 直径为 1.0 至 1.9cm 的进展期胃癌,可优先选择 LG;然而,如果 ESLN>2.5cm,LG 则不安全。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验